Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
NCT04708834
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
772
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor Decision
Conditions
Obsessive Compulsive Disorder
Interventions
DRUG:
Troriluzole (BHV-4157)
Sponsor
Biohaven Pharmaceuticals, Inc.